An evaluation of the potential for drug-drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
about
Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolitesCommonality of rituximab pharmacokinetic disposition in nephrotic syndrome and autoimmune cytopenias in chronic lymphocytic leukemia patients.Label-Free Quantification of Anti-TNF-α in Patients Treated with Adalimumab Using an Optical Biosensor.
P2860
An evaluation of the potential for drug-drug interactions between bendamustine and rituximab in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An evaluation of the potential ...... homa and mantle cell lymphoma.
@ast
An evaluation of the potential ...... homa and mantle cell lymphoma.
@en
type
label
An evaluation of the potential ...... homa and mantle cell lymphoma.
@ast
An evaluation of the potential ...... homa and mantle cell lymphoma.
@en
prefLabel
An evaluation of the potential ...... homa and mantle cell lymphoma.
@ast
An evaluation of the potential ...... homa and mantle cell lymphoma.
@en
P2093
P2860
P1476
An evaluation of the potential ...... homa and mantle cell lymphoma.
@en
P2093
Edward Hellriegel
Elizabeth Ludwig
John M Burke
Luann Phillips
Mihaela C Munteanu
Mona Darwish
Philmore Robertson
P2860
P2888
P304
P356
10.1007/S00280-014-2445-5
P577
2014-03-28T00:00:00Z
P5875
P6179
1030147742